CRISIL has acquired 26,22,430 equity shares or 8.90% of CARE Ratings. The company has acquired the same at a price of Rs 1659.79 per share, on June 29, 2017.
CRISIL is a global analytical company providing ratings, research and risk & policy advisory services. It rates the entire range of debt instruments: bank loans, certificates of deposit, commercial paper, non-convertible debentures, bank hybrid capital instruments, asset-backed securities, mortgage-backed securities, perpetual bonds, and partial guarantees.
| Company Name | CMP |
|---|---|
| CRISIL | 4335.25 |
| ICRA | 5461.30 |
| Care Ratings | 1621.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: